GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Liwanli Innovation Co Ltd (TPE:3054) » Definitions » Float Percentage Of Total Shares Outstanding

Liwanli Innovation Co (TPE:3054) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 17, 2025)


View and export this data going back to 2002. Start your Free Trial

What is Liwanli Innovation Co Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Liwanli Innovation Co's float shares is 0.00 Mil. Liwanli Innovation Co's total shares outstanding is 80.65 Mil. Liwanli Innovation Co's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Liwanli Innovation Co's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Liwanli Innovation Co's Institutional Ownership is 0.01%.


Liwanli Innovation Co Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Liwanli Innovation Co's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/80.65
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Liwanli Innovation Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
Liancheng Road, No. 258, 18th Floor - 9, Zhonghe District, New Taipei City, TWN, 235
Liwanli Innovation Co Ltd is engaged in the manufacture, wholesale, and retail of electronic materials and the sales of biotech products like drug nutrient products. The reportable segments of the company are distinguished by products; the electronic department is mainly engaged in the sale and after-sales service of computer peripherals, memory and other related products; and the biotechnology department is mainly engaged in the sales of biotechnology products. Maximum revenue is generated from its Electronics department. Geographically, the company generates a majority of its revenue from Taiwan, followed by other regions.

Liwanli Innovation Co Headlines

No Headlines